Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |